Initial Discussions on Investment Opportunities for mRNA Technology in Low and Middle-Income Countries

Overview

On April 17, 2024, during the World Bank Spring Meetings, WHO, PAHO, and MPP convened a hybrid meeting to discuss financing mRNA-based technologies in LMICs. The meeting aimed to engage multilateral development banks (MDBs) and stakeholders in supporting the expansion of vaccine production and pandemic preparedness. The meeting aimed to explore investment opportunities in mRNA technology in Low and Middle-Income Countries (LMICs). The COVID-19 pandemic highlighted the disparities in vaccine distribution, emphasizing the need for localized production to improve global health equity. The meeting underscored the need for a concerted effort to develop innovative financing models and strengthen the ecosystem for mRNA technology in LMICs. The discussions highlighted the importance of collaboration, sustainability, and strategic partnerships in achieving equitable and resilient vaccine manufacturing capabilities globally. The event marked a significant step towards engaging MDBs and stakeholders in advancing mRNA technology to address global health challenges.